Print Page

其 他 安 全 警 示

 
Canada: Reminding Canadians about using acetaminophen safely(English Only)
 
With the United States Food and Drug Administration (FDA) deciding to change dosage requirements for prescription acetaminophen combination products, Health Canada is reminding Canadians about using acetaminophen safely. Health Canada continues to review emerging and available safety evidence, including that used by the FDA to reach its decision and will determine if any new action may be needed to protect health and safety.

Please refer to the following website in Health Canada for details: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2011/2011_05-eng.php

In Hong Kong, there are ten products registered which contains paracetamol (another name of acetaminophen) in combination with opioids. Most of these products are prescription drugs. In light of the new labeling requirement of FDA, the issue will be considered in the coming meeting of the Registration Committee of Pharmacy and Poisons Board. Letter to inform healthcare professionals about FDA’s decision and remind them about using acetaminophen safely will be issued. In addition, any actions from other health authorities will be kept in view.



Ends/Friday, January 14, 2011
Issued at HKT 14:30
 
Related Information:
加拿大:訊息更新 – 加拿大衞生部提出對含撲熱息痛的非處方產品的標籤准則修訂 上載於 2015-09-16
加拿大:加拿大衞生部採取新的行動以改善撲熱息痛的安全,提醒加拿大人關於使用安全 上載於 2015-07-10
中國: 含對乙醯氨基酚的感冒藥合理使用是安全的 上載於 2014-01-27
美國:藥物安全通訊:撲熱息痛處方產品的每劑量單位限制為325毫克 上載於 2014-01-15
The United States: FDA limits acetaminophen in prescription combination products... 上載於 2011-01-14
 
back